BACKGROUND: Hospital-acquired infections caused by multiresistant gram-negative bacteria are difficult to treat and cause high rates of morbidity and mortality. The analysis of antimicrobial resistance trends of gram-negative pathogens isolated from hospital-acquired infections is important for the development of antimicrobial stewardship programs. The information obtained from antimicrobial resistant programs from two hospitals from Mexico will be helpful in the selection of empiric therapy for hospital-acquired gram-negative infections. FINDINGS: Two thousand one hundred thirty two gram-negative bacteria collected between January 2005 and December 2010 from hospital-acquired infections occurring in two teaching hospitals in Mexico were ev...
AbstractThis study was to investigate the quinolone resistance to gram negative bacteria isolated in...
Antimicrobial resistance patterns of the most frequently isolated Gram-positive bacteria in selected...
Resistance rates to amikacin, ciprofloxacin, ceftazidime, cefepime, imipenem, cefoperazone/sulbactam...
Antimicrobial resistance is an increasing worldwide concern, which poses unique challenges for the e...
AimWe aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens of epi...
Antibiotic resistance is a serious public health threat, primarily, resulting from the excess and in...
Establish the susceptibility pattern of Gram-negative bacteria causing infections in ICU patients, M...
The emergence of bacterial resistance to antibacterial agents continues to be an important clinical ...
During 1997, a total of 4,267 nosocomial and community-acquired bloodstream infections due to gram-n...
BACKGROUND: Infections caused by multidrug resistant gram negative bacteria are often corresponded w...
Summary Objective: a resistance of hospital-acquired bacteria to multiple antibiotics is a major con...
This study was conducted to evaluate the relationship between antimicrobial resistance and antimicro...
Objective: To investigate the antimicrobial resistance among non-fermenting gramnegative bacilli, pa...
The antimicrobial susceptibility of 176 unusual non-fermentative gram-negative bacilli (NF-GNB) col...
The antimicrobial susceptibility of 176 unusual non-fermentative gram-negative bacilli (NF-GNB) col...
AbstractThis study was to investigate the quinolone resistance to gram negative bacteria isolated in...
Antimicrobial resistance patterns of the most frequently isolated Gram-positive bacteria in selected...
Resistance rates to amikacin, ciprofloxacin, ceftazidime, cefepime, imipenem, cefoperazone/sulbactam...
Antimicrobial resistance is an increasing worldwide concern, which poses unique challenges for the e...
AimWe aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens of epi...
Antibiotic resistance is a serious public health threat, primarily, resulting from the excess and in...
Establish the susceptibility pattern of Gram-negative bacteria causing infections in ICU patients, M...
The emergence of bacterial resistance to antibacterial agents continues to be an important clinical ...
During 1997, a total of 4,267 nosocomial and community-acquired bloodstream infections due to gram-n...
BACKGROUND: Infections caused by multidrug resistant gram negative bacteria are often corresponded w...
Summary Objective: a resistance of hospital-acquired bacteria to multiple antibiotics is a major con...
This study was conducted to evaluate the relationship between antimicrobial resistance and antimicro...
Objective: To investigate the antimicrobial resistance among non-fermenting gramnegative bacilli, pa...
The antimicrobial susceptibility of 176 unusual non-fermentative gram-negative bacilli (NF-GNB) col...
The antimicrobial susceptibility of 176 unusual non-fermentative gram-negative bacilli (NF-GNB) col...
AbstractThis study was to investigate the quinolone resistance to gram negative bacteria isolated in...
Antimicrobial resistance patterns of the most frequently isolated Gram-positive bacteria in selected...
Resistance rates to amikacin, ciprofloxacin, ceftazidime, cefepime, imipenem, cefoperazone/sulbactam...